This analysis was a planned extension of the previously published ARCTIC-Monitoring trial , in which we randomly allocated 2440 patients to a strategy of platelet function testing with antiplatelet treatment adjustment or a conventional strategy after coronary stenting with drug-eluting stent ( DES ) .